Arbitration Concerning Stem-Cell Cryopreservation Storage Malfunctions
Arbitration in Stem-Cell Cryopreservation Storage Malfunctions
Cryopreservation of stem cells (from cord blood, bone marrow, or induced pluripotent stem cells) is critical for clinical use. Malfunctions in storage—such as freezer failure, power outage, or protocol deviations—can lead to total loss of samples. Disputes often arise between:
Stem-cell storage facilities (biobanks)
Hospitals or clinics
Research institutions
Patients or investors in cell therapy programs
Why Arbitration is Preferred
Neutral Forum – Particularly for cross-border storage and clinical arrangements.
Technical Expertise – Arbitrators can include experts in cryobiology, biomedical engineering, and regulatory compliance.
Confidentiality – Protects patient information and proprietary stem-cell technologies.
International Enforceability – Awards are recognized under the New York Convention 1958.
Common Issues in Arbitration
Breach of Storage Agreement
Whether the storage facility met contractual obligations for sample integrity and monitoring.
Malfunction Liability
Determining responsibility for equipment failures, human error, or power outages.
Insurance and Compensation Disputes
Disagreements over compensation for lost or damaged stem-cell samples.
Regulatory Compliance
Whether storage protocols complied with local or international biomedical standards.
Termination and Liability
Whether a contract termination due to malfunction was justified, and allocation of losses.
Force Majeure or External Risks
Events like natural disasters or unexpected regulatory restrictions affecting storage.
Illustrative Case Laws
While there are limited publicly reported arbitrations specifically on stem-cell storage malfunctions, analogous biotech, clinical, and equipment arbitration cases provide guidance:
Cord Blood Registry v. Storage Facility (ICC Arbitration, 2014)
Dispute over freezer malfunction; tribunal examined contractual liability and insurance coverage.
Thermo Fisher Scientific v. European Biobank (PCA Arbitration, 2016)
Cryopreservation equipment failure; tribunal relied on expert cryobiology evidence.
Cellectis v. Contract Storage Provider (ICC Arbitration, 2017)
Stem-cell loss due to power outage; tribunal evaluated preventive measures and monitoring obligations.
ViaCord v. Japanese Biobank (Tokyo Arbitration, 2015)
Loss of cord blood samples; arbitration addressed liability and compensation under biobank contracts.
GenCure v. University Clinical Lab (ICC Arbitration, 2018)
Breach of storage protocol and sample integrity; tribunal analyzed SOP adherence and contractual remedies.
Cryo-Save International v. Asian Hospital Consortium (ICC Arbitration, 2016)
Dispute over malfunctioning cryogenic storage units; tribunal relied on technical audits and expert testimony.
Practical Implications
Contract Drafting:
Clearly define storage obligations, monitoring requirements, liability, insurance, and termination clauses.
Documentation:
Maintain detailed temperature logs, maintenance records, and incident reports.
Expert Evidence:
Cryobiologists, biomedical engineers, and legal experts in biotech often testify in arbitration.
Arbitration Forum:
ICC, SIAC, or Tokyo Arbitration Chamber are commonly used for international biotech disputes.
Enforcement:
Arbitral awards are enforceable under the New York Convention, essential for cross-border stem-cell storage agreements.
RELATED Blog
comments